Immunomodulatory therapy in genetic mouse models of progressive multiple sclerosis

被引：0
|
作者：
Groh, J. [1 ]
Hoerner, M. [1 ]
Buttmann, M. [2 ]
Martini, R. [1 ]
机构：
[1] Univ Hosp Wuerzburg, Dept Neurol, Dev Neurobiol, Wurzburg, Germany
[2] Univ Hosp Wuerzburg, Dept Neurol, Wurzburg, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P430
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [41] Characterization of brain lesions in a mouse model of progressive multiple sclerosis
    Levy, H.
    Assaf, Y.
    Frenkel, D.
    EXPERIMENTAL NEUROLOGY, 2010, 226 (01) : 148 - 158
  • [42] Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
    Gilli, Francesca
    Royce, Darlene B.
    Pachner, Andrew R.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (117):
  • [43] Immunomodulatory networks in multiple sclerosis
    Ntranos, Achillefs
    Lee, Brian
    Xie, Hui
    Rockoff, Jonathan
    Brandstadter, Rachel
    Kim-Schulze, Seunghee
    Lublin, Fred
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [44] Genetic determinants of mitochondrial impairment in primary progressive multiple sclerosis
    Sorosina, Melissa
    Misra, Kaalindi
    Clarelli, Ferdinando
    Mascia, Elisabetta
    Giordano, Antonino
    Scire, Sara
    Ferre, Laura
    Cannizzaro, Miryam
    Crotti, Michela
    De Ritis, Daniele
    Maltecca, Francesca
    Filippi, Massimo
    Esposito, Federica
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 804 - 804
  • [45] Genetic determinants of mitochondrial impairment in primary progressive multiple sclerosis
    Sorosina, Melissa
    Mascia, Elisabetta
    Crotti, Michela
    Clarelli, Ferdinando
    Giordano, Antonino
    Ferre, Laura
    De Ritis, Daniele
    Maltecca, Francesca
    Filippi, Massimo
    Esposito, Federica
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1489 - 1490
  • [46] A Comparison of Complement System Activation between a Mouse Model of Relapsing Remitting Multiple Sclerosis and a Mouse Model of Progressive Multiple Sclerosis
    Linzey, M.
    DiSano, K.
    Welsh, N.
    Gilli, F.
    Pachner, A.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 97 - 98
  • [47] Progressive multiple sclerosis 1 Pathological mechanisms in progressive multiple sclerosis
    Mahad, Don H.
    Trapp, Bruce D.
    Lassmann, Hans
    LANCET NEUROLOGY, 2015, 14 (02): : 183 - 193
  • [48] Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis
    Lizak, Nathaniel
    Lugaresi, Alessandra
    Alroughani, Raed
    Lechner-Scott, Jeannette
    Slee, Mark
    Hodgkinson, Suzanne
    Jokubaitis, Vilija
    Spelman, Tim
    Butzkueven, Helmut
    Kalincik, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (14) : NP14 - NP14
  • [49] Escalating immunomodulatory therapy of multiple sclerosis - new aspects and practical application
    Rieckmann, P
    Toyka, KV
    NERVENARZT, 2002, 73 (06): : 556 - 563
  • [50] Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis
    Lizak, Nathaniel S.
    Lugaresi, Alessandra
    Alroughani, Raed
    Lechner-Scott, Jeanette
    Slee, Mark
    Jokubaitis, Vilija
    Spelman, Tim
    Butzkueven, Helmut
    Kalincik, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 16 - 17
12345